AUM $8.19BER 0.44%NAV $169.83Holdings 254Inception Feb 2001
Price Chart
Key Statistics
Previous Close
$167.81Day Range
$164.75$166.92
52-Week Range
$116.63$177.64
Avg Volume
1.2MDividend Yield
0.23%Expense Ratio
0.44%AUM
$8.19BShares Outstanding
48.3METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 88.28% |
| Netherlands | 3.71% |
| Denmark | 2.12% |
| United Kingdom | 1.73% |
| Canada | 0.84% |
| Germany | 0.78% |
| Ireland | 0.61% |
| France | 0.52% |
| Switzerland | 0.50% |
| China | 0.17% |
| Jersey | 0.12% |
| Spain | 0.10% |
| Singapore | 0.10% |
| Australia | 0.09% |
| Belgium | 0.09% |
| Italy | 0.07% |
| Cayman Islands | 0.07% |
| Other | 0.06% |
| Iceland | 0.03% |
| Taiwan (Province of China) | 0.01% |
Fund Information
- Issuer
- iShares
- Category
- Healthcare
- Types
- Biotech
- Inception Date
- Feb 5, 2001
- Exchange
- NASDAQ
- Description
- The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
Similar ETFs
The iShares Biotechnology ETF (IBB) is an exchange-traded fund issued by iShares that launched on Feb 5, 2001. It currently manages $8.19B in assets under management. The fund charges an expense ratio of 0.44%. The fund holds 254 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 45.6% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | AMGN | AMGEN INC | 7.32% | 1,738,554 | $606.1M |
| 2 | GILD | GILEAD SCIENCES INC | 7.32% | 4,529,789 | $605.4M |
| 3 | VRTX | VERTEX PHARMACEUTICALS INC | 7.14% | 1,358,257 | $591.0M |
| 4 | REGN | REGENERON PHARMACEUTICALS INC | 7.04% | 760,596 | $582.6M |
| 5 | ALNY | ALNYLAM PHARMACEUTICALS INC | 3.73% | 982,696 | $308.4M |
| 6 | ARGX | ARGENX SE ADR | 3.26% | 342,630 | $270.0M |
| 7 | INSM | INSMED INC | 2.77% | 1,592,840 | $229.1M |
| 8 | BIIB | BIOGEN INC | 2.48% | 1,094,448 | $205.6M |
| 9 | NTRA | NATERA INC | 2.39% | 983,679 | $197.9M |
| 10 | UTHR | UNITED THERAPEUTICS CORP | 2.19% | 316,493 | $181.3M |
| 11 | RVMD | REVOLUTION MEDICINES INC | 2.09% | 1,287,082 | $173.1M |
| 12 | ONC | BEONE MEDICINES AG | 1.92% | 530,793 | $159.1M |
| 13 | MRNA | MODERNA INC | 1.72% | 2,699,253 | $142.7M |
| 14 | INCY | INCYTE CORP | 1.70% | 1,472,501 | $140.6M |
| 15 | ILMN | ILLUMINA INC | 1.68% | 1,110,744 | $139.3M |
Page 1 of 6
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | -1.40% | |
| 1W | -4.99% | |
| 1M | +2.13% | |
| 3M | -5.13% | |
| 6M | +3.72% | |
| YTD | -2.18% | |
| 1Y | +32.52% | |
| 3Y | +25.68% | |
| 5Y | +6.90% |
Moving Averages
20-Day MA
$171.79
Below 20-Day MA50-Day MA
$170.22
Below 50-Day MA200-Day MA
$157.83
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$177.64
Current Price
$165.31
52-Week Low
$116.63
$116.63$177.64
Current Yield
0.23%
Annual Dividend
$0.4495
Frequency
4x/year
Last Ex-Date
Dec 16, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 16, 2025 | $0.1831 | Dec 19, 2025 |
| Sep 16, 2025 | $0.0828 | Sep 19, 2025 |
| Mar 18, 2025 | $0.1212 | Mar 21, 2025 |
| Dec 17, 2024 | $0.0624 | Dec 20, 2024 |
| Sep 25, 2024 | $0.2005 | Sep 30, 2024 |
| Mar 21, 2024 | $0.1260 | Mar 27, 2024 |
| Dec 20, 2023 | $0.1240 | Dec 27, 2023 |
| Sep 26, 2023 | $0.1532 | Oct 2, 2023 |
| Jun 7, 2023 | $0.0062 | Jun 13, 2023 |
| Mar 23, 2023 | $0.0646 | Mar 29, 2023 |
| Dec 13, 2022 | $0.1014 | Dec 19, 2022 |
| Sep 26, 2022 | $0.1586 | Sep 30, 2022 |
| Jun 9, 2022 | $0.0305 | Jun 15, 2022 |
| Mar 24, 2022 | $0.1176 | Mar 30, 2022 |
| Dec 13, 2021 | $0.0413 | Dec 17, 2021 |
| Sep 24, 2021 | $0.1244 | Sep 30, 2021 |
| Jun 10, 2021 | $0.0232 | Jun 16, 2021 |
| Mar 25, 2021 | $0.1311 | Mar 31, 2021 |
| Dec 14, 2020 | $0.0655 | Dec 18, 2020 |
| Sep 23, 2020 | $0.0632 | Sep 29, 2020 |
Dividend Payments Over Time
Category Comparison
| Metric | IBB | Healthcare(212 ETFs) | Biotech(41 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.44% | 0.61% | 0.83% |
| AUM | $8.19B | $1.20B | $1.52B |
| Dividend Yield | 0.23% | 3.25% | 1.97% |
| Avg Volume | 1.2M | 339.2K | 689.3K |
| Holdings | 254 | 181 | 66 |
| Performance | |||
| 1-Month Return | +4.61% | +7.61% | +5.92% |
| 6-Month Return | +8.15% | +4.67% | +5.84% |
| YTD Return | -0.57% | +1.95% | -0.96% |
| 1-Year Return | +36.19% | +27.17% | +37.04% |
Compare with Another ETF
Search for an ETF to compare with IBB:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.